Our Leadership Team

Dean Hart, Chief Executive Officer

Dean brings 35 years of extensive and broad biopharmaceutical experience to RS BioTherapeutics including roles of increasing responsibility at Bristol-Myers Squibb, Eisai, Takeda Pharmaceuticals North America, and Adamas Pharmaceuticals. Dean has built, launched and led organizations for two multi-billion dollar brands. For the past 9 years, Dean has been consulting with small, mid and large biopharmaceutical companies in driving different facets of Commercial Excellence including Launch Excellence and has provided consulting for brands in several markets. Dean earned a Master of Business of Administration from the Kellogg School of Management at Northwestern University and a B.S. in Business Management and Administration from the Kelly School of Business at Indiana University.

Justin Molignoni, CRNP, Chief Strategy Officer

Justin is a Co-Founder of RS BioTherapeutics, entering medicine as an RN and then an NP working in Critical Care and Emergency Medicine with secondary focus on primary care and nephrology. His research has been presented at the Institute for Healthcare Improvement as well as published by the Society of Critical Care Medicine. In 2019, Justin was recognized as one of the Top 100 Healthcare Leaders by the International Forum on Advancements in Healthcare. He also speaks regionally and nationally on the Endocannabinoid System. Justin earned a Master of Science Nurse Practitioner from Simmons Collins Graduate Studies, an Associate’s degree, Registered Nursing from Pennsylvania College of Health Sciences, and a Bachelor’s degree, Business Administration and Management and Physics from Juniata College.

Dr. Debra Kimless, M.D, Chief Scientific Officer

Dr. Kimless, M.D. graduated magna cum laude, Phi Beta Kappa from Muhlenberg College with a double major in Natural Sciences and Biology. She attended medical school at Rutgers, and residency at Temple University Hospital and is a board-certified Anesthesiologist with a subspecialty certification in Pain Medicine and is board certified by the American/International Lifestyle Medicine Board. Dr. Kimless entered into the medical cannabis field in 2013. She consults within the industry as the Clinical Director of Research for Laurel Harvest Labs in collaboration with Temple University, Chief Medical Officer for Pure Green Pharmaceuticals (PGP), Medical Director for ForwardGro a medical cannabis cultivation, and the Chief Science Officer for Merida Capital Partners. Dr. Kimless is considered among a few expert physicians who understand the power and importance of the endocannabinoid system and its influence on every biologic system.

Jeremy Plumb, Chief Cultivation Officer

Jeremy is the Director of Production Science at Groundworks Industries and at Prūf Cultivar, one of the most technologically advanced cannabis cultivation facilities in North America. At Prūf, Jeremy combines decades of cannabis horticulture experience with cutting-edge technology to deliver previously unattainable consistency in both product quality and consumer effect. Prior to his leadership at Prūf, Jeremy was a co-founder of Farma, recently acclaimed by Rolling Stone as one of Oregon’s top dispensaries. Jeremy has served as a cannabis consultant to Israel medical cannabis researchers and as a cannabis policy advisor for US members of Congress. He also serves on the OLCC’s rule-making advisory committee. In 2015, Jeremy co-founded Cultivation Classic, Oregon’s leading craft cannabis competition. He is also a founding member of Smart Cannabis and serves on the technical advisory committee of the Resource Innovation Institute. Jeremy earned a M.A. Psychology from Pacifica Graduate Institute and a B.A., Ecology from New College of California.

Michael Guzman, JD, Chief of Staff

Michael has over 16 years of experience working in the healthcare arena. He currently serves as the Chief Operating Officer for a physical medicine and pain management practice. He previously served as a Healthcare Consultant where he guided and supported customers across the post-acute care continuum to elevate revenue streams; improve workflow, operations, and logistics; and increase regulatory compliance. He also acted as a Corporate Compliance Officer and Lead Internal Investigator for a middle market rehabilitation company, where he supervised up to 12 teams across six states. Michael completed a Juris Doctorate and a Master of Science in Occupational Therapy from the University of Puerto Rico.